2021

Life Sciences

BacVax, Inc.

Year
2021

BacVax designs and develops vaccines against bacterial infections utilizing a novel structural approach based on bioinformatics.

Company Status

Active

U of A Inventors

College

Life Sciences

PhytoCentric Solutions, LLC

Year
2021

PhytoCentric Solutions provides testing sevices to the food industry and has developed proprietary natural antimicrobial products for consumer applications.

Company Status

Active

U of A Inventors

College

Life Sciences

NeuTherapeutics, LLC

Year
2021

NeuTherapeutics is developing regenerative treatments and precision therapies to prevent, halt and cure neurodegenerative diseases.

Company Status

Active

U of A Inventors

College

Life Sciences

NightRighter, Inc.

Year
2021

NightRighter is a provider-focused, web-based learning course in cognitive behavioral therapy for insomnia.

Company Status

Active

U of A Inventors

Life Sciences

Luxxon Therapeutics, LLC

Year
2021

Luxxon Therapeutics is developing light-based therapies for chronic pain.

Company Status

Inactive

U of A Inventors

College

Physical Sciences

Revolute Robotics, LLC

Year
2021

Revolute Robotics provides a new generation of robots that can operate in any domain for extended periods of time.

Company Status

Active

U of A Inventors

College

Life Sciences

Lean Life Sciences, Inc.

Year
2021

Lean Life Sciences is developing highly effective anti-obesity supplements without the significant health risks and severe side effects posed by other anti-obesity drugs.

Company Status

Active

U of A Inventors

College

Life Sciences

MeCo Diagnostics, LLC

Year
2021

MeCo Diagnostics is developing a "Mechanical Conditioning" Multi-Gene score for prediction and intervention of breast cancer bone metastasis.

Company Status

Active

College

Life Sciences

uPetsia, Inc.

Year
2021

Engineered bacteria for dog and cat oral microbiota to improve health and breath. 

Company Status

Inactive

U of A Inventors

College

Life Sciences

Module Therapeutics, Inc.

Year
2021

Module therapeutics is commercializing cell therapies using novel engineered receptors, known as 5MCARs, to precisely target and eliminate disease causing T cells. Elimination of these pathogenic cells will elicit durable therapeutic benefits to patients suffering from autoimmune disease.

Company Status

Active

U of A Inventors

College